MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, VRCA has $47,131K in assets. $22,388K in debts. $30,147K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
258.80%
Quick Ratio
245.20%
Cash Ratio
183.41%
Debt to Asset Ratio
47.50%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Total current liabilities
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
30,147
Accounts receivable
5,260
Collaboration revenue, billed and unbilled
137
Deferred r&d services, current portion (note 12)
1,958
Inventory
2,236
Prepaid expenses and other current assets
2,801
Total current assets
42,539
Property and equipment, net
209
Operating lease right-of-use asset
540
Finance lease right-of-use asset
1,113
Deferred r&d services, non-current portion (note 12)
2,354
Other non-current assets
376
Total assets
47,131
Accounts payable
2,072
Accrued expenses and other current liabilities
12,837
Deferred revenue
782
Current portion of long-term debt
0
Operating lease liability
341
Finance lease liability
405
Total current liabilities
16,437
Operating lease liability
242
Finance lease liability
643
Derivative liability
0
R&d funding liability (note 12)
5,066
Long-term debt
0
Total liabilities
22,388
Common stock, 0.0001 par value 200,000,000 authorized 17,189,300 shares issued and 17,178,786 shares outstanding as of december31, 2025 and 9,188,513 shares issued and 9,177,999 shares outstanding as of december31, 2024
2
Treasury stock, at cost, 10,514 shares as of december 31, 2025 and december 31, 2024
0
Additional paid-in capital
349,654
Accumulated deficit
-324,913
Total stockholders (deficit) equity
24,743
Total liabilities and stockholders (deficit) equity
47,131
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$30,147K Accounts receivable$5,260K Prepaid expenses andother current assets$2,801K Inventory$2,236K Deferred r&d services,current portion (note...$1,958K Collaboration revenue, billedand unbilled$137K Total current assets$42,539K Deferred r&d services,non-current portion (note...$2,354K Finance leaseright-of-use asset$1,113K Operating leaseright-of-use asset$540K Other non-currentassets$376K Property and equipment,net$209K Total assets$47,131K Total liabilities andstockholders (deficit)...$47,131K Total stockholders(deficit) equity$24,743K Total liabilities$22,388K Accumulated deficit-$324,913K Additional paid-in capital$349,654K Total currentliabilities$16,437K R&d fundingliability (note 12)$5,066K Finance lease liability$643K Operating lease liability$242K Common stock, 0.0001par value...$2K Accrued expenses andother current...$12,837K Accounts payable$2,072K Deferred revenue$782K Finance lease liability$405K Operating lease liability$341K

Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Inc. (VRCA)